Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make winning trades in the stock market.
Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.
CELH
$40.84+Infinity%1D
Analyst Views on CELH
Wall Street analysts forecast CELH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELH is 65.00 USD with a low forecast of 50.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
17 Analyst Rating
Wall Street analysts forecast CELH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CELH is 65.00 USD with a low forecast of 50.00 USD and a high forecast of 80.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Buy
1 Hold
1 Sell
Strong Buy
Current: 43.150
Low
50.00
Averages
65.00
High
80.00
Current: 43.150
Low
50.00
Averages
65.00
High
80.00
Piper Sandler
Overweight
downgrade
$69 -> $61
2025-12-17
New
Reason
Piper Sandler
Price Target
$69 -> $61
2025-12-17
New
downgrade
Overweight
Reason
Piper Sandler lowered the firm's price target on Celsius to $61 from $69 and keeps an Overweight rating on the shares. The firm says the company's sales growth looks on track in Q4 2025, with shipments on Alani Nu likely ahead of sellthrough and with modest inventory de-stocking on Celsius.
KeyBanc
initiated
2025-12-16
New
Reason
KeyBanc
Price Target
2025-12-16
New
initiated
Reason
KeyBanc initiated coverage of Celsius with a Sector Weight rating.
KeyBanc
Christopher Carril
Sector Weight
initiated
2025-12-16
New
Reason
KeyBanc
Christopher Carril
Price Target
2025-12-16
New
initiated
Sector Weight
Reason
As previously reported, KeyBanc analyst Christopher Carril initiated coverage of Celsius (CELH) with a Sector Weight rating. The company represents a compelling growth story within its peer set, but this has largely been reflected in share price, with the stock up 66% year-to-date, the analyst tells investors in a research note. The stock's upside looks somewhat limited given the moving pieces of the operating model, including the integration of Alani Nu into the Pepsi (PEP) distribution system, but there could be opportunity to become more constructive once past these integrations, the firm added.
UBS
Peter Grom
Buy
downgrade
$73 -> $65
2025-11-07
Reason
UBS
Peter Grom
Price Target
$73 -> $65
2025-11-07
downgrade
Buy
Reason
UBS analyst Peter Grom lowered the firm's price target on Celsius to $65 from $73 and keeps a Buy rating on the shares. Celsius shares traded lower as Q3 results fell short of an elevated bar, the analyst tells investors in a research note. The firm views the move lower as overdone.
About CELH
Celsius Holdings, Inc. is engaged in the development, processing, marketing, sale, and distribution of functional energy drinks to a range of consumers. The Company's flagship asset, CELSIUS, is marketed as a lifestyle and energy drink. This product line comes in two versions: a ready-to-drink form and an on-the-go powder form. It also offers a new CELSIUS Essentials line, available in 16-ounce cans and a Hydration line of zero-sugar powders that are infused with electrolytes and are available in a variety of fruit-forward flavors. Celsius products are offered in retail channels across the United States, including conventional grocery, natural, convenience, fitness, mass market, vitamin specialty and e-commerce platforms. Its product's formulation includes ingredients and supplements such as green tea (EGCG), ginger (from the root), calcium, chromium, B vitamins and vitamin C. The Company's product portfolio also includes the health and wellness brand Alani Nu.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
